Patent · US Active

Process of making a crystalline EDG-2 receptor antagonist

US12391640B2 · kind B2 · utility

0Cited by
36References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 1, 2023
Grant dateAug 19, 2025
Priority date—
Expiry dateApr 12, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2602/08
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Described herein are methods of making crystalline Form 1 of 2-(4-methoxy-3-(3-methylphenethoxy)benzamido)-2,3-dihydro-1H-indene-2-carboxylic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.